Clinical features and prognostic implications of familial hypertrophic cardiomyopathy related to the cardiac myosin-binding protein C gene

scientific article published in June 1998

Clinical features and prognostic implications of familial hypertrophic cardiomyopathy related to the cardiac myosin-binding protein C gene is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1161/01.CIR.97.22.2230
P698PubMed publication ID9631872

P50authorMichel KomajdaQ64498753
P2093author name stringRichard P
Charron P
Hainque B
Camproux AC
Dubourg O
Schwartz K
Carrier L
Isnard R
Bonne G
Bouhour JB
Desnos M
Bennaceur M
Langlard JM
Hagege A
P433issue22
P407language of work or nameEnglishQ1860
P921main subjectfamilial hypertrophic cardiomyopathyQ56014654
hypertrophic cardiomyopathyQ1364270
P304page(s)2230-2236
P577publication date1998-06-01
P1433published inCirculationQ578091
P1476titleClinical features and prognostic implications of familial hypertrophic cardiomyopathy related to the cardiac myosin-binding protein C gene
P478volume97

Reverse relations

cites work (P2860)
Q91359304A novel MYBPC3 c.2737+1 (IVS26) G>T mutation responsible for high-risk hypertrophic cardiomyopathy
Q77616527A novel deletion mutation in the cardiac myosin-binding protein C gene as a cause of Maron's type IV hypertrophic cardiomyopathy
Q28182167A novel missense mutation in the myosin binding protein-C gene is responsible for hypertrophic cardiomyopathy with left ventricular dysfunction and dilation in elderly patients
Q57907349Acquis et perspective de la génétique des myocardiopathies
Q33379935Adverse events in families with hypertrophic or dilated cardiomyopathy and mutations in the MYBPC3 gene
Q38295649Altered myocardial gene expression reveals possible maladaptive processes in heterozygous and homozygous cardiac myosin-binding protein C knockout mice
Q34275552American College of Cardiology/European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the Euro
Q34286730Clinical and echocardiographic features of hypertrophic cardiomyopathy in the elderly
Q64997486Clinicopathological and Genetic Profiles of Cases with Myocytes Disarray-Investigation for Establishing the Autopsy Diagnostic Criteria for Hypertrophic Cardiomyopathy.
Q37629210Contractile dysfunction in a mouse model expressing a heterozygous MYBPC3 mutation associated with hypertrophic cardiomyopathy
Q74353552Development of left ventricular hypertrophy in adults in hypertrophic cardiomyopathy caused by cardiac myosin-binding protein C gene mutations
Q24681653Double heterozygosity for mutations in the beta-myosin heavy chain and in the cardiac myosin binding protein C genes in a family with hypertrophic cardiomyopathy
Q30328020Effects of a cardiomyopathy-causing troponin t mutation on thin filament function and structure.
Q34430364FHL2 expression and variants in hypertrophic cardiomyopathy
Q37672736Familial hypertrophic cardiomyopathy associated with a new mutation in gene MYBPC3.
Q28283579Founder mutations in hypertrophic cardiomyopathy patients in the Netherlands
Q77429816Genes and disease expression in hypertrophic cardiomyopathy
Q34673385Genes and their polymorphisms in mono- and multifactorial cardiomyopathies: towards pharmacogenomics in heart failure
Q35145962Genetic advances in sarcomeric cardiomyopathies: state of the art.
Q36712985Genetic complexity in hypertrophic cardiomyopathy revealed by high-throughput sequencing
Q37786123Genetic counselling and testing in cardiomyopathies: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases
Q37125766Genetic determinants of cardiac hypertrophy
Q37766140Genetic evaluation of familial cardiomyopathy
Q38058475Genetic testing in the contemporary diagnosis of cardiomyopathy
Q57907337Génétique des cardiomyopathies hypertrophiques
Q28138779Hypercontractile properties of cardiac muscle fibers in a knock-in mouse model of cardiac myosin-binding protein-C
Q82093356Hypertrophic cardiomyopathy
Q45339581Hypertrophic cardiomyopathy clinical phenotype is independent of gene mutation and mutation dosage
Q33147359Hypertrophic cardiomyopathy complicated by severe bradycardias: a pedigree report
Q42339402Hypertrophic cardiomyopathy in daily practice: an introduction on diagnosis, prognosis and treatment
Q38203157Hypertrophic cardiomyopathy: how do mutations lead to disease?
Q35113389Hypertrophic cardiomyopathy:a paradigm for myocardial energy depletion
Q33167969Hypertrophic obstructive cardiomyopathy
Q46348368Impact of QT variables on clinical outcome of genotyped hypertrophic cardiomyopathy.
Q77947888Late-onset primary LVH HCM versus cardiac fabry variant
Q37101872MYBPC3 gene variations in hypertrophic cardiomyopathy patients in India
Q37949516Mechanisms of disease: hypertrophic cardiomyopathy
Q34641881Modifier genes for hypertrophic cardiomyopathy
Q34469735Molecular genetic basis of sudden cardiac death
Q34021080Molecular genetics and pathogenesis of hypertrophic cardiomyopathy
Q36344118Molecular genetics in hypertrophic cardiomyopathy: towards individualized management of the disease
Q34027457Molecular genetics of hypertrophic cardiomyopathy
Q36299735Multiple forms of cardiac myosin-binding protein C exist and can regulate thick filament stability
Q37490943Mutation Analysis of Three Exons of Myosin-Binding Protein C3 in Patients with Hypertrophic Cardiomyopathy
Q44354566Mutations in MYH7 reduce the force generating capacity of sarcomeres in human familial hypertrophic cardiomyopathy
Q51149024Myocardial Scar Visualized by Cardiovascular Magnetic Resonance Imaging Predicts Major Adverse Events in Patients With Hypertrophic Cardiomyopathy
Q34028344Myocardial fibrosis detected by cardiac CT predicts ventricular fibrillation/ventricular tachycardia events in patients with hypertrophic cardiomyopathy
Q33145751Natural history of hypertrophic cardiomyopathy
Q34445272Novel genotype-phenotype associations demonstrated by high-throughput sequencing in patients with hypertrophic cardiomyopathy
Q42735759On genetic and phenotypic variability of hypertrophic cardiomyopathy: nature versus nurture
Q39367648Recent advances in genetics and treatment of hypertrophic cardiomyopathy
Q35580191Relation between QT duration and maximal wall thickness in familial hypertrophic cardiomyopathy
Q73682058Relation between severity of left-ventricular hypertrophy and prognosis in patients with hypertrophic cardiomyopathy
Q34759446Research priorities in hypertrophic cardiomyopathy: report of a Working Group of the National Heart, Lung, and Blood Institute.
Q33158326Risk stratification for sudden cardiac death in hypertrophic cardiomyopathy: systematic review of clinical risk markers
Q36369925Sarcomeric proteins and familial hypertrophic cardiomyopathy: linking mutations in structural proteins to complex cardiovascular phenotypes
Q35758994Screening Mutations of MYBPC3 in 114 Unrelated Patients with Hypertrophic Cardiomyopathy by Targeted Capture and Next-generation Sequencing
Q33569089Screening mutations in myosin binding protein C3 gene in a cohort of patients with Hypertrophic Cardiomyopathy
Q52962652Spectrum of clinical phenotypes and gene variants in cardiac myosin-binding protein C mutation carriers with hypertrophic cardiomyopathy.
Q33148988Subclinical skeletal muscle abnormalities in patients with hypertrophic cardiomyopathy and their relation to clinical characteristics
Q44057427T-peak to T-end interval may be a better predictor of high-risk patients with hypertrophic cardiomyopathy associated with a cardiac troponin I mutation than QT dispersion.
Q35743765The Metabolome in Finnish Carriers of the MYBPC3-Q1061X Mutation for Hypertrophic Cardiomyopathy
Q77096691The electrocardiogram as a diagnostic tool for hypertrophic cardiomyopathy: revisited
Q33942334The genomics of cardiovascular disorders: therapeutic implications
Q57907347The heart of genomics
Q33939892The molecular genetic basis for hypertrophic cardiomyopathy
Q35771667The pathology of hypertrophic cardiomyopathy
Q64232857Three perspectives on the molecular basis of hypercontractility caused by hypertrophic cardiomyopathy mutations
Q42748756To screen or not is not the question--it is when and how to screen
Q36057314Toward Personalized Medicine: Does Genetic Diagnosis of Pediatric Cardiomyopathy Influence Patient Management?
Q34425285Two novel mutations of the MYBPC3 gene identified in Chinese families with hypertrophic cardiomyopathy
Q82388219Use of genetics in the clinical evaluation and management of heart failure
Q74430979Usefulness of Doppler myocardial imaging for identification of mutation carriers of familial hypertrophic cardiomyopathy
Q31158025Usefulness of Genetic Testing in Hypertrophic Cardiomyopathy: an Analysis Using Real-World Data
Q36366148Vulnerable myocardial interstitium in patients with isolated left ventricular hypertrophy and sudden cardiac death: a postmortem histological evaluation
Q52936185[Cardiomyopathies II. Hypertrophic cardiomyopathy, restrictive cardiomyopathy, arrhythmogenic right ventricular cardiomyopathy].
Q74043611[Genetically modified animal models in cardiovascular research]

Search more.